This content is machine translated Parkinson's disease Individualized therapy concepts are essential After Alzheimer’s disease, Parkinson’s disease is currently the second most common neurodegenerative disease. The majority of those affected are ≥60 years old when it first manifests, but a minority develop...…
View Post 6 min This content is machine translated Parkinson’s disease and movement disorders Technological and digital support of the future Current developments and new trends were the focus of this year’s congress on Parkinson’s disease and movement disorders. In view of the enormous growth in knowledge from preclinical and clinical…
View Post 2 min This content is machine translated Parkinson's disease Tracking the variability of phenotypes Whereas earlier disease concepts assumed that patients with PD would follow a rather uniform clinical course within their disease entities (PD, PSP, CBD, MSA), more recent cohort data show that…
View Post 3 min This content is machine translated Parkinson's disease What is still possible when seemingly nothing else works Contemporary Parkinson’s therapy is multidisciplinary and is based on the individual needs of the patient. The experts at the dgp-Congress agreed. Increasing understanding of disease progression will enable personalized treatment,…
View Post 2 min This content is machine translated Parkinson's disease Updates in the management of Parkinson’s syndrome Shaking hands, stiff muscles, unsteady gait – the typical signs of Parkinson’s disease. Up to now only symptomatically treatable, intensive research is being conducted to find an individual therapeutic approach.…
View Post 5 min This content is machine translated Parkinson's disease What to do in case of respiratory disorders? Pneumologic and neurologic dysfunction occur equally in PD and are typical of the disease. It is therefore important to be mutually considerate: Pneumologists must not disregard the fact that respiratory…
View Post 5 min This content is machine translated Parkinson's disease From clinical syndrome to molecular diagnostics and modern therapy Parkinson’s syndrome is one of the most common neurodegenerative diseases. Symptoms such as limitations in movement control are based on a loss of nerve cells in the affected areas of…
View Post 2 min This content is machine translated Parkinson's disease What to do when fluctuations occur? Effect fluctuations are a common phenomenon in the course of Parkinson’s disease. This results in late complications such as on-off phenomena or dyskinesias. So far, they cannot be prevented, but…
View Post 4 min This content is machine translated Internal Medicine Update Refresher Parkinson’s disease – levodopa, and what else? For decades, the foundations of idiopathic Parkinson’s syndrome treatment have remained unshaken. Nevertheless, research into this clinical picture has, of course, by no means come to a standstill. It is…
View Post 7 min This content is machine translated Drug treatment strategies What to do if levodopa is no longer stored? Therapy of PD must always be individualized and its onset should take into account the patient’s level of suffering. Initially, almost all antiparkinsonian drugs can be used with success, but…
View Post 5 min This content is machine translated Deep brain stimulation in Parkinson's disease An effective alternative to drug therapy Levodopa treatment in Prakinson’s disease often results in motor fluctuations and dyskinesias. For selected patients in advanced stages, deep brain stimulation, which works by applying high-frequency pulses to specific brain…
